接受左旋多巴治疗的帕金森综合征患者脑脊液中的5-羟吲哚乙酸 - Suppr

Suppr

超能文献

5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.

作者信息

Johansson B, Roos B E

出版信息

Eur J Clin Pharmacol. 1971 Sep;3(4):232-5. doi: 10.1007/BF00565012.

DOI:10.1007/BF00565012

PMID:5151306

Abstract

摘要

相似文献

5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.接受左旋多巴治疗的帕金森综合征患者脑脊液中的5-羟吲哚乙酸

Eur J Clin Pharmacol. 1971 Sep;3(4):232-5. doi: 10.1007/BF00565012.

Central monoamine metabolism in Parkinson's disease.帕金森病中的中枢单胺代谢

Arch Neurol. 1972 Dec;27(6):486-91. doi: 10.1001/archneur.1972.00490180022006.

Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.单独使用左旋多巴或与脱羧酶抑制剂联合治疗的帕金森病患者脑脊液中的酸性单胺代谢产物。

Eur Neurol. 1973;9(6):349-62. doi: 10.1159/000114243.

Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease.帕金森病左旋多巴治疗期间的高香草酸（HVA）和5-羟吲哚乙酸（5HIAA）

Neurology. 1970 Apr;20(4):377.

Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.帕金森病脑脊液中的胺类代谢产物及其对左旋多巴的反应。

J Neurol Sci. 1973 May;19(1):1-12. doi: 10.1016/0022-510x(73)90050-6.

Predictive value of the probenecid test for the effect of L-DOPA therapy in Parkinson's disease.

Nat New Biol. 1972 Apr 19;236(68):208-9. doi: 10.1038/newbio236208a0.

On the relationship between L-DOPA therapy and CSF monoamine metabolites in Parkinson's disease.关于帕金森病中左旋多巴治疗与脑脊液单胺代谢物之间的关系

Z Neurol. 1973 Apr 2;204(2):149-54. doi: 10.1007/BF00315939.

The effect of L-dopa on monoamine metabolites in Parkinson's disease.左旋多巴对帕金森病中单胺代谢产物的影响。

Experientia. 1970;26(2):161-3. doi: 10.1007/BF01895555.

3 -Methoxy- 4 -hydroxyphenylethylene glycol in human cerebrospinal fluid.人脑脊液中的3-甲氧基-4-羟基苯乙二醇

Clin Chim Acta. 1971 Nov;35(1):145-50. doi: 10.1016/0009-8981(71)90305-6.

Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease.

Neurology. 1972 Jan;22(1):62-7. doi: 10.1212/wnl.22.1.62.

引用本文的文献

Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.帕金森病患者的脑脊液生化研究：寻找这种疾病潜在生物标志物的方法。

Front Cell Neurosci. 2014 Nov 11;8:369. doi: 10.3389/fncel.2014.00369. eCollection 2014.

On the relationship between L-DOPA therapy and CSF monoamine metabolites in Parkinson's disease.关于帕金森病中左旋多巴治疗与脑脊液单胺代谢物之间的关系

Z Neurol. 1973 Apr 2;204(2):149-54. doi: 10.1007/BF00315939.

Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.左旋多巴及左旋多巴+RO 4-4602治疗的帕金森病患者临床症状、脑脊液中高香草酸（HVA）和5-羟吲哚乙酸（5-HIAA）与血浆左旋多巴的相关性

Eur J Clin Pharmacol. 1977 Apr 20;11(4):255-61. doi: 10.1007/BF00607673.

本文引用的文献

L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.L-多巴：对小鼠脑内多巴胺、去甲肾上腺素和 5-羟色胺浓度的影响。

Science. 1970 May 15;168(3933):849-50. doi: 10.1126/science.168.3933.849.

EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM.中枢神经系统中单胺能神经元存在的证据。IV. 中枢神经系统中单胺能神经末梢的分布。

Acta Physiol Scand Suppl. 1965:SUPPL 247:37+.

DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS.黑质-新纹状体多巴胺能神经元的显示与定位

Life Sci (1962). 1964 Jun;3:523-30. doi: 10.1016/0024-3205(64)90161-4.

[Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].[5-羟色胺（血清素）在人脑中的分布及其在帕金森综合征患者中的表现]

Klin Wochenschr. 1961 Oct 15;39:1056-9. doi: 10.1007/BF01487648.

5-Hydroxyindoles in human cerebrospinal fluids.人脑脊液中的5-羟基吲哚

Nature. 1960 Jun 25;186:1050-1. doi: 10.1038/1861050a0.

Are dihydroxphenylalanine decarboxylase and 5-hydroxytrptophan decarboxylase individual enzymes?二羟基苯丙氨酸脱羧酶和5-羟色氨酸脱羧酶是不同的酶吗？

Acta Physiol Scand. 1960 Aug 25;49:364-9. doi: 10.1111/j.1748-1716.1960.tb01958.x.

[Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].[去甲肾上腺素和多巴胺（3-羟酪胺）在人脑内的分布及其在锥体外系疾病中的表现]

Klin Wochenschr. 1960 Dec 15;38:1236-9. doi: 10.1007/BF01485901.

5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.健康志愿者和帕金森综合征患者脑脊液中5-羟吲哚乙酸和高香草酸水平

Life Sci. 1967 Jul 1;6(13):1449-54. doi: 10.1016/0024-3205(67)90193-2.

Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.丙磺舒治疗前及治疗期间犬脑脊液中5-羟吲哚乙酸和高香草酸的浓度。

Life Sci. 1966 Sep;5(17):1571-5. doi: 10.1016/0024-3205(66)91026-5.

Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism.老年痴呆、早老性痴呆和帕金森病患者脑脊液中的高香草酸和5-羟吲哚乙酸

J Neurochem. 1969 Sep;16(9):1341-5. doi: 10.1111/j.1471-4159.1969.tb05984.x.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验